Evidence map›Paper›PMID 39554677›Full record

ArticlePakistan journal of medical sciences2024

Ilizarov versus ORIF for Open AO Type-C Pilon Fractures.

Saeed A Shaikh, Dr Malik Osama Tanveer, Muhammad Tahir, Nadeem Ahmed

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. [Clinical advances in Ilizarov technique for foot and ankle trauma].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saeed A ShaikhDr. Saeed A Shaikh, FCPS, Department of Orthopaedics, Surgical Building, Jinnah Postgraduate Medical Centre, Rafiqui Shaheed Road, Karachi, Pakistan.
Dr Malik Osama TanveerDr Malik Osama Tanweer, FCPS. Consultant Orthopaedics, Faculty of Surgery, South City Institute of Physical Therapy and Rehabilitation, Karachi, Pakistan.
Muhammad TahirMr. Muhammad Tahir, MRCS Eng, FCPS, Department of Orthopaedics, Surgical Building, Jinnah Postgraduate Medical Centre, Rafiqui Shaheed Road, Karachi, Pakistan.
Nadeem AhmedDr. Nadeem Ahmed, FCPS, Department of Orthopaedics, Surgical Building, Jinnah Postgraduate Medical Centre, Rafiqui Shaheed Road, Karachi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to evaluate the clinical effectiveness of ORIF versus Ilizarov for the management of Type C closed pilon fractures of the distal tibia at 12 months follow up. Methods: This retrospective cross sectional study was conducted at Jinnah Postgraduate Medical Center (JPMC) between 29 Results: Fifteen patients underwent ORIF, while 26 patients were treated with Ilizarov, there was no statistically significant difference in DRI scores at 12 months between the two groups. In terms of clinical outcomes, both groups had comparable results throughout the follow-up period. The number of unplanned surgical procedures was not statistically significant (p=0.73), 26.92% (n=7) in the Ilizarov as compared to 33.33% (n=5) in the ORIF group. Conclusion: Among patients with an acute, displaced, intra-articular fracture of the distal tibia, neither external fixation nor locking plate fixation resulted in superior disability status at 12 months. Patient factors may need to be considered in deciding the optimal approach.

Indexed as

AOFAS-Ankle Hindfoot ScoreArthritisOpen fracturePainPilon fracture

Identifiers

PMID39554677
PMCPMC11568736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.